Category: Nutritional & Digestive Drivers

Most people think of gluten as a digestive issue — a problem for the gut, felt as bloating or diarrhea. But some of the most important consequences of gluten sensitivity are neurological, and they can appear in people whose intestines seem perfectly fine. Gluten can injure the nervous system directly, producing peripheral neuropathy and balance problems even in the complete absence of celiac disease. This article explains the immune mechanism behind that, why standard celiac testing so often misses it, and what the evidence says about dietary elimination.

Gluten sensitivity is not only celiac disease

Celiac disease is an autoimmune reaction to gluten that damages the small intestine. But researchers — most prominently Dr. Marios Hadjivassiliou and colleagues in Sheffield, UK — have spent decades documenting a broader category of gluten-related disorders in which the primary target is not the gut but the nervous system. In many of these patients, intestinal biopsy is normal or near-normal, and yet the neurological damage is real and progressive.

This matters enormously, because a patient with gluten neuropathy who is told “your celiac test is negative, so gluten isn’t your problem” may continue eating the very trigger that is dismantling their nerves.

Molecular mimicry: how the immune system confuses nerves for gluten

The central mechanism is molecular mimicry. When the immune system mounts a response to gluten, it produces antibodies. In susceptible people, some of those antibodies cross-react with the body’s own tissues because a molecular structure in nervous tissue resembles the gluten fragment closely enough to be mistaken for it.

A key player is an enzyme family called transglutaminase. In celiac disease, the immune attack targets transglutaminase-2, concentrated in the gut. In gluten-related neurological disease, antibodies against transglutaminase-6 (TG6) — an isoform expressed in the nervous system — have been identified as a marker of the neural attack. Antibodies can also target the myelin that insulates nerves. The result is an immune assault on the peripheral nerves (neuropathy) and, in some patients, on the cerebellum, producing gluten ataxia — a loss of coordination and balance.

What gluten neuropathy feels like

Gluten neuropathy most often presents as a length-dependent sensory neuropathy: tingling, numbness, and burning that begin in the feet. Because it develops slowly and can occur without digestive symptoms, it is frequently mislabeled as idiopathic. When the cerebellum is involved, patients may notice unsteadiness, a wide-based gait, or clumsiness that they attribute to aging. The combination of an unexplained sensory neuropathy and subtle balance problems should raise the question of gluten sensitivity.

Why the celiac test misses it

Standard celiac screening looks for the intestinal form of the disease — typically tissue transglutaminase-2 (tTG) antibodies and evidence of gut damage. It is not designed to detect the neurological form. A patient can have a completely negative celiac panel and still be producing the TG6 and anti-myelin antibodies driving nerve injury. This is why a negative celiac test does not rule out gluten as a cause of neuropathy — a point explored further in the companion article on negative celiac testing.

Genetic testing (for the HLA-DQ2/DQ8 haplotypes that predispose to gluten sensitivity) and expanded antibody panels give a more complete picture than a routine celiac screen alone.

The role of strict elimination

Because the damage is driven by an ongoing immune response to gluten, the logical — and evidence-supported — intervention is strict, sustained gluten elimination. Hadjivassiliou’s group has reported that patients who adhere rigorously to a gluten-free diet can see stabilization and, in some cases, improvement of their neurological symptoms, while partial or inconsistent avoidance is often insufficient. Nerve tissue recovers slowly, so improvement, when it comes, unfolds over months, and the earlier the trigger is removed, the more function there is to preserve.

“Strict” is the operative word. Unlike a lifestyle preference, therapeutic gluten elimination for neurological disease means eliminating cross-contamination and hidden sources — not simply cutting back on bread. This is best done with dietary guidance and monitoring.

Where this fits in a root-cause evaluation

Gluten is one driver among several that can masquerade as idiopathic neuropathy. In a thorough workup it is evaluated alongside metabolic, toxic, and mechanical contributors, because more than one can be present at once. The value of identifying a gluten contribution is that it is, in principle, entirely removable — the trigger is on the plate.

Frequently asked questions

Key takeaways

• Gluten can injure nerves and the cerebellum directly, independent of celiac disease.
• The mechanism is immune molecular mimicry, with transglutaminase-6 antibodies marking the neural attack.
• Standard celiac tests do not detect the neurological form; a negative result does not clear gluten.
• Strict, sustained gluten elimination is the evidence-supported intervention, with slow, partial recovery possible.
• Gluten is evaluated alongside other neuropathy drivers, and is uniquely removable.

Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not make major dietary or medication changes without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Hadjivassiliou M, Grünewald RA, Davies-Jones GAB. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72:560–563.
2. Hadjivassiliou M, et al. Transglutaminase-6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80:1740–1745.
3. Hadjivassiliou M, et al. Gluten neuropathy. Muscle Nerve / Brain (peripheral neuropathy series).
4. Hadjivassiliou M, et al. Neurologic deficits in patients with gluten sensitivity — role of strict gluten-free diet.

Note: match each reference to the specific paper at publication; the Sheffield group has an extensive body of work in this area.

One of the most treatable causes of peripheral neuropathy is also one of the most frequently missed — not because doctors don’t test for it, but because the usual test can read “normal” while the deficiency is doing real damage at the cellular level. This article explains why a serum B12 result can be misleading, which functional markers reveal what it hides, and the full roster of nutrients your nerves depend on to function and to heal.

Why a “normal” B12 can be wrong

The standard test measures the total amount of vitamin B12 circulating in your blood. The problem is that this number does not necessarily reflect how much B12 is actually available and working inside your cells. A substantial portion of measured B12 is bound to a protein that cannot deliver it to tissues, so the total can look adequate while the metabolically active supply is low. Reference ranges also vary, and results in the low-normal zone are commonly reported as fine even when a patient is symptomatic.

The consequence is a patient with the classic tingling, numbness, and imbalance of a B12-related neuropathy being told their levels are “normal,” while the underlying deficiency quietly progresses. Untreated, B12 deficiency can damage not only peripheral nerves but the spinal cord itself — and while early damage is reversible, advanced damage may not be.

The functional markers that tell the truth: MMA and homocysteine

To see what serum B12 hides, clinicians use functional markers — substances that accumulate when B12 is inadequate at the cellular level, regardless of what the total blood level says.

Methylmalonic acid (MMA). B12 is a required cofactor for the enzyme that processes methylmalonyl-CoA. When B12 is functionally deficient inside cells, this reaction stalls and MMA builds up. An elevated MMA is a sensitive and relatively specific sign of true B12 deficiency at the tissue level.

Homocysteine. B12 (along with folate and B6) is needed to convert homocysteine into methionine. When B12 is functionally low, homocysteine rises. Elevated homocysteine is less specific than MMA — it can also reflect folate or B6 deficiency — but together the two markers give a far more accurate picture than serum B12 alone.

Checking MMA and homocysteine can catch a functional deficiency that a normal B12 would have masked, allowing correction before permanent nerve or spinal-cord injury occurs.

Common reasons B12 runs low

Functional B12 deficiency is especially worth checking in several situations. Metformin, one of the most-prescribed diabetes medications, interferes with B12 absorption and can produce deficiency over years of use — a cruel irony in patients whose diabetes is already threatening their nerves. Acid-suppressing drugs (PPIs and H2 blockers) reduce the stomach acid needed to liberate B12 from food. Age reduces absorption, as can autoimmune (pernicious) causes, gastrointestinal surgery, and strict plant-based diets. Anyone with unexplained neuropathy and any of these risk factors deserves functional testing.

B12 is not alone: the nutrient team your nerves need

B12 gets the headlines, but nerves depend on a whole team of cofactors, and deficiency of any one can impair function or healing.

Thiamine (B1). Essential for glucose metabolism and mitochondrial energy production. Thiamine deficiency directly causes neuropathy, and it is often depleted in diabetes and in heavy alcohol use. The work of Dr. Hammes and colleagues highlighted how thiamine-dependent pathways protect against the biochemical damage of high blood sugar — part of the rationale for the thiamine derivative benfotiamine.

Vitamin B6. Required for nerve function and neurotransmitter synthesis — but with an important caveat: both deficiency and excess can cause neuropathy, so B6 supplementation should be measured and monitored, not open-ended.

Magnesium. A cofactor in hundreds of enzymatic reactions, including those governing nerve excitability and mitochondrial energy. Deficiency contributes to nerve hyperexcitability and is common in diabetes.

Omega-3 fatty acids. Structural components of nerve membranes with anti-inflammatory effects; adequate intake supports the membrane integrity and the inflammatory balance that healthy nerves require.

The mitochondrial common thread

Notice the recurring theme: nearly every one of these nutrients feeds into mitochondrial energy production. A nerve is an energy-intensive structure, and it fails when its power supply falters. This is why correcting deficiencies is not simply “topping up vitamins” — it is restoring the cell’s ability to make energy, repair itself, and maintain its signaling. Functional nutrient testing, and correction guided by that testing, is a foundational part of a root-cause neuropathy plan rather than an afterthought.

What to do with this information

The practical message is to test properly and correct precisely. That means functional markers (MMA, homocysteine) rather than serum B12 alone, evaluation of thiamine and magnesium status, a review of medications that deplete these nutrients (without stopping needed prescriptions on your own), and repletion tailored to what the testing shows. Because some deficiencies (like B6) can harm in excess, and because absorption problems may require specific forms or routes of supplementation, this is best done under medical guidance.

Frequently asked questions

Key takeaways

• A “normal” serum B12 can hide a cellular deficiency that damages nerves and even the spinal cord.
• Functional markers — methylmalonic acid and homocysteine — reveal true tissue-level deficiency.
• Metformin, acid-suppressing drugs, age, and GI issues are common causes worth screening for.
• Nerves also depend on thiamine, B6 (in balance), magnesium, and omega-3s, mostly via mitochondrial energy.
• Test functionally and correct precisely, under guidance — don’t self-dose blindly.

Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication or supplement without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368:149–160.
2. Aroda VR, et al. Long-term metformin use and vitamin B12 deficiency (Diabetes Prevention Program Outcomes Study). J Clin Endocrinol Metab. 2016.
3. Hammes HP, et al. Benfotiamine blocks three major pathways of hyperglycemic damage. Nat Med. 2003;9:294–299.
4. Ghavanini AA, Kimpinski K. Revisiting the evidence for neuropathy caused by pyridoxine (B6) deficiency and excess. J Clin Neuromuscul Dis. 2014.

You did the responsible thing. You mentioned your burning feet, someone ordered a celiac panel, it came back negative, and gluten was crossed off the list. But for a large number of people with gluten-related nerve damage, that negative result is exactly where the diagnosis goes wrong. The celiac test is answering a different question than the one your nerves are asking. This article explains why standard celiac screening misses gluten neuropathy, and what testing actually reveals it.

The celiac test answers the wrong question

Celiac disease is defined by an immune attack on the small intestine. Its screening tools are built to detect that — chiefly antibodies to tissue transglutaminase-2 (tTG-2), the transglutaminase isoform concentrated in the gut, confirmed by intestinal biopsy showing damage to the villi.

Gluten-related neurological disease is a different manifestation of gluten sensitivity. The immune response targets the nervous system, and the gut may be entirely spared. A patient can therefore have a pristine celiac panel and normal intestinal biopsy while producing the antibodies that are injuring their peripheral nerves. The test isn’t broken — it’s simply looking in the wrong place.

What the immune system actually targets in the nerves

As covered in the companion article on the gluten–neuropathy connection, the mechanism is molecular mimicry. Two targets are especially relevant to a nerve-focused workup.

Transglutaminase-6 (TG6). This isoform is expressed in nervous tissue, and antibodies against it — described by Dr. Marios Hadjivassiliou’s group — mark the neurological form of gluten sensitivity. TG6 antibodies can be present when the gut-focused tTG-2 antibodies are absent, which is precisely why a celiac screen can miss neurological disease.

Anti-myelin and related antibodies. The immune response can also target components of the myelin sheath that insulates nerves, contributing to the sensory neuropathy and, when the cerebellum is involved, the ataxia seen in gluten-related neurological disease.

The genetics: HLA-DQ2 and HLA-DQ8

Gluten sensitivity has a strong genetic underpinning. The great majority of people who react to gluten — whether the celiac or the neurological form — carry one of two immune-system genetic markers, HLA-DQ2 or HLA-DQ8. Testing for these haplotypes is informative in a different way than antibody testing: a negative HLA-DQ2/DQ8 result makes gluten-driven disease very unlikely and can effectively rule it out, while a positive result establishes susceptibility (though not everyone who is susceptible develops disease). This makes HLA typing a useful gatekeeping test in an unexplained neuropathy workup.

Building a proper gluten-neuropathy panel

For someone with an unexplained sensory neuropathy — especially with any balance disturbance — a more complete evaluation than a routine celiac screen includes HLA-DQ2/DQ8 genetic typing, an expanded gluten-related antibody panel (including TG6 where available, alongside the conventional celiac antibodies), and a clinical assessment for the length-dependent sensory pattern and any cerebellar signs. The aim is to catch the neurological form that the standard screen is not designed to see.

An important practical caveat: antibody testing is most meaningful while gluten is still in the diet. If a patient has already gone gluten-free, antibody levels may fall and produce falsely reassuring results — something to plan around with a clinician before testing.

Why it’s worth the effort

Chasing down a gluten contribution is worthwhile because, unlike many drivers of neuropathy, it is entirely removable — the trigger is dietary. When gluten-related neurological disease is confirmed and strict elimination is undertaken early, symptoms can stabilize and sometimes improve. The tragedy of the missed diagnosis is that the person keeps eating the trigger for years, attributing their progressive nerve damage to bad luck or aging, when a change on the plate could have changed the trajectory.

This is one driver among several

Gluten sensitivity is one possible contributor evaluated within a broader root-cause investigation that also weighs metabolic, toxic, and mechanical causes. Because multiple drivers frequently coexist, ruling gluten in or out is part of assembling the complete picture rather than a search for a single culprit.

Frequently asked questions

Key takeaways

• Standard celiac tests detect intestinal disease, not the neurological form of gluten sensitivity.
• Transglutaminase-6 (TG6) antibodies mark the neural attack and can be present with a negative celiac panel.
• HLA-DQ2/DQ8 typing is a useful gatekeeper: a negative result largely rules gluten out.
• Test while still eating gluten, since prior elimination can produce falsely negative antibodies.
• Confirmed gluten neuropathy is uniquely treatable, because the trigger is removable.

Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not make major dietary or medication changes without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Hadjivassiliou M, et al. Transglutaminase-6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80:1740–1745.
2. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318–330.
3. Hadjivassiliou M, et al. Gluten-related neurological dysfunction and HLA associations.
4. Volta U, et al. Serological tests in gluten-related disorders. Cell Mol Immunol / review.

Some neuropathies trace back to an event that happened years earlier — an operation that solved one problem while quietly setting up another. Surgeries that alter the digestive tract, including bariatric (weight-loss) procedures and gallbladder removal, can impair the absorption of nutrients the nervous system depends on. The nerve damage may appear months or years later, long after anyone is thinking about the surgery, which is exactly why the deficiency so often goes unchecked. This article explains how it happens, which nutrients are at risk, and why lifelong monitoring is the answer.

How digestive surgery leads to nerve damage

Nutrient absorption is a choreographed process that depends on specific parts of the digestive tract, specific stomach secretions, and — for fats and fat-soluble vitamins — bile. Surgery that changes this anatomy or physiology can disrupt absorption even when a person eats well.

Bariatric surgery works partly by reducing how much you eat and, in some procedures, by bypassing sections of the intestine where nutrients are absorbed. It also reduces stomach acid and intrinsic factor, both needed to absorb vitamin B12. The result is a well-documented, long-term risk of multiple nutrient deficiencies.

Gallbladder removal (cholecystectomy) changes how bile is delivered to the intestine. Because bile is essential for absorbing dietary fat and the fat-soluble vitamins (A, D, E, and K), some people develop impaired fat absorption afterward, which over time can affect nutrients like vitamin E — a deficiency specifically linked to neurological problems.

The common thread is malabsorption: the food goes in, but the nutrients don’t fully get where they need to go.

The nutrients at risk — and the nerves they protect

Several deficiencies after digestive surgery are directly relevant to nerve health.

Vitamin B12. Highly vulnerable after procedures that reduce stomach acid and intrinsic factor. B12 deficiency causes a characteristic neuropathy and can damage the spinal cord.

Thiamine (B1). Can become deficient rapidly, especially with vomiting or poor intake after surgery, and thiamine deficiency causes neuropathy and, acutely, can precipitate the neurological emergency Wernicke’s encephalopathy. This is one to catch early.

Copper. An underrecognized but important one. Copper deficiency — which can follow bariatric surgery (and is worsened by excessive zinc intake) — causes a myeloneuropathy, damaging both peripheral nerves and the spinal cord, sometimes mimicking B12 deficiency. It is frequently missed precisely because few clinicians think to check it.

Fat-soluble vitamins (especially vitamin E). Impaired fat absorption, more relevant after gallbladder-related changes and malabsorptive procedures, can lead to vitamin E deficiency, which causes a distinct neurological syndrome including neuropathy and balance problems.

Other B vitamins and minerals. Folate, B6, and others can also run low, compounding the picture.

Why it’s so often missed

The delay is the problem. Nutrient stores can take months or years to deplete, so the neuropathy often appears well after the surgery, by which time neither the patient nor a new clinician necessarily connects the two. Copper and vitamin E, in particular, are not on most routine panels, so they go unchecked unless someone specifically thinks of them. A patient can end up labeled with idiopathic neuropathy when the real cause is a treatable, surgery-related deficiency that simply wasn’t on anyone’s radar.

The answer: lifelong monitoring and repletion

The solution is straightforward in principle and requires diligence in practice. Anyone who has had bariatric surgery — and those with malabsorption after other digestive procedures — needs lifelong nutritional monitoring, including the nutrients that routine panels skip. That means periodic checks of B12 (functionally, with MMA and homocysteine), thiamine, copper, and the fat-soluble vitamins including vitamin E, along with folate and others as indicated, and repletion tailored to what testing shows.

Repletion sometimes requires specific forms or routes (for example, higher-dose or non-oral B12) because the absorption problem that caused the deficiency also affects how supplements are absorbed. This is why post-surgical nutritional care is an ongoing medical partnership, not a one-time fix — and when a neuropathy does appear, checking this full panel can reveal a cause that is genuinely correctable.

Where this fits

Post-surgical malabsorption is one of the nutritional/metabolic drivers considered in a complete neuropathy workup. Its signature is the combination of an unexplained neuropathy and a history of digestive surgery — a history worth volunteering to any clinician evaluating nerve symptoms, because it points straight at a set of specific, testable deficiencies.

Frequently asked questions

Key takeaways

• Bariatric and gallbladder surgery can impair nutrient absorption and cause delayed neuropathy.
• Key nutrients at risk: B12, thiamine, copper, and fat-soluble vitamins (especially vitamin E).
• Copper and vitamin E deficiencies are commonly missed because they aren’t on routine panels.
• The delay between surgery and symptoms is why the cause is so often overlooked.
• Lifelong monitoring and tailored repletion can prevent and reverse these deficiencies.

Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change supplements or medication without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Kumar N. Neurologic complications of bariatric surgery. Continuum (Minneap Minn). 2014.
2. Jaiser SR, Winston GP. Copper deficiency myelopathy and neuropathy. J Neurol. 2010;257:869–881.
3. Becker DA, et al. Neurological complications of nutritional deficiency following bariatric surgery. J Obes. 2012.
4. Kumar N. Nutritional neuropathies (vitamin E, B12, thiamine, copper). Neurol Clin. 2007.